echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > The storage, transport and inoculation temperature of Moderna's new crown vaccine has significant advantages

    The storage, transport and inoculation temperature of Moderna's new crown vaccine has significant advantages

    • Last Update: 2020-11-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Moderna announced that its COVID-19 vaccine candidate mRNA-1273 will remain stable for 30 days at 2 to 8 degrees C (standard household or medical refrigerator temperature), for six months at -20 degrees C and for 12 hours at room temperature. juan Andres, chief technology operations and quality officer at
    Moderna, said: "Investments in mRNA delivery technology and manufacturing processes have enabled us to store and transport COVID-19 candidate vaccines at existing drug cold storage and storage tanks.
    Our ability to keep vaccines at -20 degrees C for up to 6 months and in a normal refrigerator for 30 days will make vaccine distribution simpler and more flexible for large-scale vaccination in the United States and other parts of the world.
    " transport and long-term storage: the transport and long-term storage of the mRNA-1273 vaccine will be maintained at -20 degrees C, equivalent to the temperature of most home or medical freezers.
    the standard freezing temperature of -20 degrees C is an easier and more mature distribution and storage temperature than ultra-low temperature freezing, and most pharmaceutical companies have the ability to store and transport products at temperatures of -20 degrees Celsius worldwide.
    storage: After melting, the mRNA-1273 vaccine will be stored under standard refrigeration conditions of 2 to 8 degrees C for up to 30 days for easy storage at the time of dosing.
    conditions can be implemented in most pharmacies, hospitals or doctor's offices.
    at room temperature: take the vaccine out of the fridge for dosing and keep it at room temperature for up to 12 hours.
    no dilution of the vaccination site: the vaccine does not require on-site dilution or special treatment, which facilitates vaccination in a variety of environments, including pharmacies and doctor's offices.
    Moderna expects to gather more stability information in the coming months to assess whether mRNA-1273 can be transported and stored under increasingly flexible conditions.
    mRNA-1273 COVID-19 vaccine is Moderna's 10th mRNA vaccine to enter the clinic.
    with its experience in preventive vaccine development and investments in mRNA platforms and delivery technologies, Moderna has developed proprietary lipid nanoparticle technology for delivery of mRNA.
    picture source: moderna.com
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.